BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35793362)

  • 1. A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor.
    Sjöbom U; Nilsson AK; Gyllensten H; Hellström A; Löfqvist C
    PLoS One; 2022; 17(7):e0270232. PubMed ID: 35793362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Measurement of Vascular Endothelial Growth Factor in Small Blood Samples of Premature Infants.
    Lopez Yomayuza CC; Preissner KT; Lorenz B; Stieger K
    Sci Rep; 2019 May; 9(1):6744. PubMed ID: 31043645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis.
    Song M; Wang H; Ye Q
    Syst Rev; 2020 May; 9(1):103. PubMed ID: 32375879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Evans JR
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants.
    Mariduena J; Ramagopal M; Hiatt M; Chandra S; Laumbach R; Hegyi T
    J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1517-1522. PubMed ID: 32366142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients.
    Hetland ML; Christensen IJ; Lottenburger T; Johansen JS; Svendsen MN; Hørslev-Petersen K; Nielsen L; Nielsen HJ
    Dis Markers; 2008; 24(1):1-10. PubMed ID: 18057530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia.
    Procianoy RS; Hentges CR; Silveira RC
    Am J Perinatol; 2016 Apr; 33(5):480-5. PubMed ID: 26529476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF levels in patients with glioma: a systematic review and meta-analysis.
    Seyedmirzaei H; Shobeiri P; Turgut M; Hanaei S; Rezaei N
    Rev Neurosci; 2021 Feb; 32(2):191-202. PubMed ID: 33125340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
    Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
    Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longchain polyunsaturated fatty acid supplementation in preterm infants.
    Moon K; Rao SC; Schulzke SM; Patole SK; Simmer K
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD000375. PubMed ID: 27995607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study.
    Voller SB; Chock S; Ernst LM; Su E; Liu X; Farrow KN; Mestan KK
    Early Hum Dev; 2014 Apr; 90(4):195-200. PubMed ID: 24480606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM; Blann AD; Lip GY
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis.
    Taher NO; Ghaddaf AA; Al-Ghamdi SA; Homsi JJ; Al-Harbi BJ; Alomari LK; Almarzouki HS
    Front Med (Lausanne); 2022; 9():884608. PubMed ID: 35615084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.
    Chuai Y; Rizzuto I; Zhang X; Li Y; Dai G; Otter SJ; Bharathan R; Stewart A; Wang A
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013348. PubMed ID: 33661538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.